197 related articles for article (PubMed ID: 26504486)
1. Identifying New Candidate Genes and Chemicals Related to Prostate Cancer Using a Hybrid Network and Shortest Path Approach.
Yuan F; Zhou Y; Wang M; Yang J; Wu K; Lu C; Kong X; Cai YD
Comput Math Methods Med; 2015; 2015():462363. PubMed ID: 26504486
[TBL] [Abstract][Full Text] [Related]
2. Mining for novel tumor suppressor genes using a shortest path approach.
Chen L; Yang J; Huang T; Kong X; Lu L; Cai YD
J Biomol Struct Dyn; 2016; 34(3):664-75. PubMed ID: 26209080
[TBL] [Abstract][Full Text] [Related]
3. Mining for Candidate Genes Related to Pancreatic Cancer Using Protein-Protein Interactions and a Shortest Path Approach.
Yuan F; Zhang YH; Wan S; Wang S; Kong XY
Biomed Res Int; 2015; 2015():623121. PubMed ID: 26613085
[TBL] [Abstract][Full Text] [Related]
4. Identification of New Candidate Genes and Chemicals Related to Esophageal Cancer Using a Hybrid Interaction Network of Chemicals and Proteins.
Gao YF; Yuan F; Liu J; Li LP; He YC; Gao RJ; Cai YD; Jiang Y
PLoS One; 2015; 10(6):e0129474. PubMed ID: 26058041
[TBL] [Abstract][Full Text] [Related]
5. Global risk transformative prioritization for prostate cancer candidate genes in molecular networks.
Chen L; Tai J; Zhang L; Shang Y; Li X; Qu X; Li W; Miao Z; Jia X; Wang H; Li W; He W
Mol Biosyst; 2011 Sep; 7(9):2547-53. PubMed ID: 21735017
[TBL] [Abstract][Full Text] [Related]
6. Pathway crosstalk analysis based on protein-protein network analysis in prostate cancer.
Wang JM; Wu JT; Sun DK; Zhang P; Wang L
Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1235-42. PubMed ID: 23047508
[TBL] [Abstract][Full Text] [Related]
7. Computational identification of surrogate genes for prostate cancer phases using machine learning and molecular network analysis.
Li R; Dong X; Ma C; Liu L
Theor Biol Med Model; 2014 Aug; 11():37. PubMed ID: 25151146
[TBL] [Abstract][Full Text] [Related]
8. Prioritization of potential candidate disease genes by topological similarity of protein-protein interaction network and phenotype data.
Luo J; Liang S
J Biomed Inform; 2015 Feb; 53():229-36. PubMed ID: 25460206
[TBL] [Abstract][Full Text] [Related]
9. Mining featured biomarkers associated with prostatic carcinoma based on bioinformatics.
Piao G; Wu J
Biomarkers; 2013 Nov; 18(7):580-6. PubMed ID: 23957850
[TBL] [Abstract][Full Text] [Related]
10. A network biology approach to prostate cancer.
Ergün A; Lawrence CA; Kohanski MA; Brennan TA; Collins JJ
Mol Syst Biol; 2007; 3():82. PubMed ID: 17299418
[TBL] [Abstract][Full Text] [Related]
11. Identifying Novel Candidate Genes Related to Apoptosis from a Protein-Protein Interaction Network.
Wang B; Yuan F; Kong X; Hu LD; Cai YD
Comput Math Methods Med; 2015; 2015():715639. PubMed ID: 26543496
[TBL] [Abstract][Full Text] [Related]
12. Cross-platform method for identifying candidate network biomarkers for prostate cancer.
Jin G; Zhou X; Cui K; Zhang XS; Chen L; Wong ST
IET Syst Biol; 2009 Nov; 3(6):505-12. PubMed ID: 19947776
[TBL] [Abstract][Full Text] [Related]
13. Network-based approach reveals Y chromosome influences prostate cancer susceptibility.
Khosravi P; Gazestani VH; Asgari Y; Law B; Sadeghi M; Goliaei B
Comput Biol Med; 2014 Nov; 54():24-31. PubMed ID: 25199846
[TBL] [Abstract][Full Text] [Related]
14. Integrative gene network construction for predicting a set of complementary prostate cancer genes.
Ahn J; Yoon Y; Park C; Shin E; Park S
Bioinformatics; 2011 Jul; 27(13):1846-53. PubMed ID: 21551151
[TBL] [Abstract][Full Text] [Related]
15. Oncogenes and tumor suppressor genes: comparative genomics and network perspectives.
Zhu K; Liu Q; Zhou Y; Tao C; Zhao Z; Sun J; Xu H
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S8. PubMed ID: 26099335
[TBL] [Abstract][Full Text] [Related]
16. Biomarker identification for prostate cancer and lymph node metastasis from microarray data and protein interaction network using gene prioritization method.
Arias CR; Yeh HY; Soo VW
ScientificWorldJournal; 2012; 2012():842727. PubMed ID: 22654636
[TBL] [Abstract][Full Text] [Related]
17. A computational bioinformatics analysis of gene expression identifies candidate agents for prostate cancer.
Wen DY; Geng J; Li W; Guo CC; Zheng JH
Andrologia; 2014 Aug; 46(6):625-32. PubMed ID: 23790256
[TBL] [Abstract][Full Text] [Related]
18. Exploring Drug Treatment Patterns Based on the Action of Drug and Multilayer Network Model.
Yu L; Shi Y; Zou Q; Wang S; Zheng L; Gao L
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708644
[TBL] [Abstract][Full Text] [Related]
19. [Genetic aspects in cancers of the prostate].
Cussenot O; Valeri A; Meria P; Berthon P; Fournier G; Teillac P; Mangin ; Le Duc A
Pathol Biol (Paris); 1996 Oct; 44(8):737-43. PubMed ID: 8977935
[TBL] [Abstract][Full Text] [Related]
20. Construction of a lncRNA-PCG bipartite network and identification of cancer-related lncRNAs: a case study in prostate cancer.
Liu Y; Zhang R; Qiu F; Li K; Zhou Y; Shang D; Xu Y
Mol Biosyst; 2015 Feb; 11(2):384-93. PubMed ID: 25385343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
